Cardioverter-defibrillators after MADIT-II: The balance between weight of evidence and treatment costs
Articolo
Data di Pubblicazione:
2003
Citazione:
Cardioverter-defibrillators after MADIT-II: The balance between weight of evidence and treatment costs / Boriani, Giuseppe; Biffi, M; Martignani, C; Camanini, C; Grigioni, F; Rapezzi, C; Branzi, A.. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 5:4(2003), pp. 419-425. [10.1016/S1388-9842(03)00099-0]
Abstract:
The possibility of using implantable cardioverter-defibrillators (ICDs) for primary prevention of sudden death in selected high-risk patients has prompted a series of prospective controlled studies. Recently, the MADIT II study highlighted the possibility of effective primary prevention of sudden death in patients with coronary artery disease selected by straightforward clinical data and without expensive screening (electrophysiological study). For patients with previous myocardial infarction and low left ventricular ejection fraction (
Tipologia CRIS:
Articolo su rivista
Keywords:
Cardiac Pacing, Artificial; Controlled Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Death, Sudden, Cardiac; Defibrillators, Implantable; Evidence-Based Medicine; Humans; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'
Elenco autori:
Boriani, Giuseppe; Biffi, M; Martignani, C; Camanini, C; Grigioni, F; Rapezzi, C; Branzi, A.
Link alla scheda completa:
Pubblicato in: